The interaction of CDC42 in complex with CASIN exhibited binding energy of (−7.4 kcal/mol) and MAPK7 in complex with BAY-885 displayed binding energy of (−7.3 kcal/mol), these results exhibited a much lower binding affinities as compared to SJ10, this suggesting the potential inhibitory effects of SJ10 in GBM expression CCNB1, CDC42, MAPK7, and CD44 oncogenic signatures (Figure 12, Table 2). Here, CCNB1 is linked to glioblastoma.